◆ 会议时间：2023年4月17日至21日
◆ 会议地点：美国 华盛顿

◆ 会议简介：

2023年第35届际乳头瘤病毒大会暨基础科学、临床和公共卫生研讨会(IPVC)将于2023年4月17日至21日在美国华盛顿举办，会议由国际乳头瘤病毒学会（IPVS）主办，大会将通过研讨会、邀请讲座、口头报告和海报会议等形式展示最新的研究结果，会议将包括基础科学、临床研究以及公共卫生、流行病学和实施科学三个主要主题。IPVC将汇集来自世界各地的研究人员、临床医生和其他相关卫生专业人士，一起分享在全球控制HPV疾病过程中的有关乳头瘤病毒及其相关疾病的知识和观点。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

国际乳头瘤病毒学会（IPVS）是乳头瘤病毒研究领域的国际权威组织。IPVS成立于2000年，是一个由研究动物和人类乳头瘤病毒及其相关疾病的生物医学科学家组成的非营利性国际组织，IPVS的使命是为消除乳头瘤病毒相关疾病做出贡献。

IPVC 2023 – The 35th International Papillomavirus Conference & Basic Science, Clinical and Public Health Workshops

Date: April 14- 17, 2023
Venue: Washington DC, USA

Organized by: International Papillomavirus Society (IPVS)

IPVC 2023 – The 35th International Papillomavirus Conference & Basic Science, Clinical and Public Health Workshops – will once again gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and their associated diseases, from basic science to global health impact.

摘要征集：

点此提交摘要>>>Submit Abstract>>>

Please be sure to read carefully the submission guidelines.

Dear Colleagues and Friends,

On behalf of the Organizing Committee and the Board of the International Papillomavirus Society (IPVS), we are very pleased to invite you to participate in the 35th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops (IPVC 2023) which will take place on April 17-21, 2023 in Washington DC, USA.

This will provide the opportunity to meet with colleagues again. We hope that the relocation of the meeting will allow as many participants as possible to attend IPVC 2023, as the last International Papillomavirus Conference held as an in-person meeting was in Sydney in 2018.

Indeed, we had planned for the 2023 edition to take place in Kyoto, Japan on March 27-31. However, on August 30th, 2022, a decision had to be made either to proceed with Kyoto and the risk that delegates could not enter the country for the meeting or change the location. As of late August 2022, the borders in Japan remained closed to foreign individual travellers. IPVS and the organisers were under serious time pressure relating to the contracts and resulting financial commitments that had a fixed date for agreement. It was felt strongly that the International Papillomavirus Society (IPVS) needed to make a decision by the end of August 2022 to deliver an in-person conference around March or April 2023. Our community is expecting a face-to-face conference and has made plans to attend it, hear lectures from experts, participate in discussions, meet their peers and present their work.

After a thorough review, Washington DC (USA) was identified as an adequate city to relocate IPVC 2023 to. Moving out of Japan was not an easy decision, and we are saddened that we will not be in Kyoto in 2023 as planned. We truly hope to be able to return to Japan for a future IPVC edition.

The theme of this conference is “Coming Together for HPV Elimination”. In line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, conference topics will include:

• Expanding scientific knowledge to benefit the whole community
• Prevention of HPV infection and their associated diseases and cancers especially cervical cancer
• The epidemiology and molecular biology of PVs
• Animal models for the study of papillomavirus disease
• Basic immunology and pathogenesis of PVs
• Therapeutic and prophylactic vaccines
• Changes in screening and HPV vaccination in Japan

With the overarching theme “Translation of research, new discoveries and education into clinical practice and public health to eliminate HPV and related diseases globally”, conference participants will hear about the latest research findings, scientific news, best practice updates and get opportunities for educational and networking exchanges.

The conference has been structured around 3 main tracks: Basic Science, Clinical Science and Public Health, Epidemiology, & Implementation Science. The Scientific Committee has been working hard to assemble an excellent line-up of speakers across workshops, keynote and plenary lectures but you can also expect to hear about the latest research results with the oral and poster sessions covering papillomavirus (PV)-related topics from basic science to global health impact.

Participants can expect a unique and memorable experience in the United States of America’s capital, with its captivating national museums and memorials, and a rich and diverse cultural and culinary scene.

We look forward to seeing you in Washington DC!

Yours Sincerely,

注册费：

* Available for IPVS members at the time of registration.

** Countries classification is defined according to the World Bank Country Classification. Click here for more information on the Country Classification data according to the World Bank website.

*** Online registration must be accompanied by a work address proof. The document is to be uploaded during the online registration process.

**** Online registration must be accompanied by an official letter confirming your status. (The document is to be uploaded during the online registration process.

***** IPVS Members who are mentoring pre-doctoral or post-doctoral trainees (who are also IPVS Members), can benefit from the combined mentor-trainee special rate for the 2 registrations. The details of both the mentor and the trainee should be provided in one registration.

Definition of categories:
Student – Any student who is currently enrolled as an undergraduate or graduate student and has an interest in the field of papillomaviruses and papillomavirus-related diseases
Emeritus – Researcher and healthcare professionals who have retired or ceased to work full-time but wish to maintain an interest in the papillomavirus field.
Early Career Researcher – Researcher who has completed their final degree within the last 5 years. Require a letter of support from supervisor to be submitted.
Allied Health Professional – Nurse, social worker, nutritionist, psychologist, art therapist, physician assistant, who participates in research or care and treatment of patients with HPV.

Fees for IN-PERSON Attendance experience include:

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。